Steven Cohen acquired 6.64M Precigen shares worth $29.6M. That's 0.05% of their equity portfolio (405th largest holding). The investor owns 2.21% of the outstanding Precigen stock. The first Precigen trade was made in Q1 2023. Since then Steven Cohen bought shares two more times and sold shares on two occasions. The stake costed the investor $24.3M, netting the investor a gain of 22% so far.